With treatment-resistant schizophrenia (TRS), the use of additional therapies, such as cognitive behavioral therapy (CBT), are often required when pharmacological methods prove insufficient or inconsistent. This original research reviewed 8 studies with matching eligibility criteria for participants and found that, in 5 of them, the use of CBT did contribute to a reduction of positive psychotic symptoms in patients with TRS. Recommendations for healthcare providers who work in psychiatric settings to obtain CBT training is discussed as a potential benefit to patient care.

Reference: Ryan M, Sattenspiel D, Chianese A, Rice H. CE: Original Research: Cognitive Behavioral Therapy for Symptom Management in Treatment-Resistant Schizophrenia. Am J Nurs. 2022;122(8):24-33. doi:10.1097/01.NAJ.0000854488.48801.59